Evidence map›Paper›PMID 34867949›Full record

ArticleFrontiers in immunology2021

Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma.

Tiantian Ma, Jing Shi, Yuxia Xiao, Tianyue Bian, Jincheng Wang, Lingyun Hui, Mengchang Wang, Huasheng Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tiantian MaDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jing ShiDepartment of Respiratory and Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yuxia XiaoDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Tianyue BianDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jincheng WangDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lingyun HuiClinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Mengchang WangDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Huasheng LiuDepartment of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNNorthwest University · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression level of BCMA in bone marrow of 54 MM patients was detected in this study to explore the relationship between the BCMA expression and the classification, stage, and prognostic factors of MM. The BCMA expression level of the stable group and remission group was lower than that of the newly diagnosed group and relapse group (P=0.001). There was no significant difference in BCMA expression of MM patients in different types and stages (P>0.05), but it was found that for the newly diagnosed MM patients, the BCMA expression level of IgG patients was higher than that of IgA or light-chain patients (rank average 11.20

Indexed as

Multiple MyelomaB-Cell Maturation AntigenBone MarrowFemaleHumansImmunoglobulinsImmunotherapy, AdoptiveMaleMiddle AgedNeoplasm StagingPrognosisReceptors, Chimeric AntigenB-Cell Maturation AntigenImmunoglobulinsReceptors, Chimeric AntigenB cell mature antigenBCMACAR-Tchimeric antigen receptor T cells therapyMMmultiple myeloma

Identifiers

PMID34867949
PMCPMC8637449
OpenAlexW3216914951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.